Study design and rationale of "Synergistic Effect of Combination Therapy with Cilostazol and ProbUcol on Plaque Stabilization and Lesion REgression (SECURE)" study: a double-blind randomised controlled multicenter clinical trial

Study design and rationale of "Synergistic Effect of Combination Therapy with Cilostazol and ProbUcol on Plaque Stabilization and Lesion REgression (SECURE)" study: a double-blind randomised controlled multicenter clinical trial

<p>Abstract</p> <p>Background</p> <p>Probucol, a cholesterol-lowering agent that paradoxically also lowers high-density lipoprotein cholesterol has been shown to prevent progression of atherosclerosis. The antiplatelet agent cilostazol, which has diverse antiatherogenic...

Full description

Bibliographic Details
Main Authors: Lee Myoungsook, Lee Jong, Kim Sang, Choi Seung, Kang Woong, Lee Byoung, Kim Byeong-Keuk, Ko Young-Guk, Honda Yasuhiro, Fitzerald Peter J, Shim Won-Heum
Format: Article
Language:English
Published: BMC 2011-01-01
Series:Trials
Online Access:http://www.trialsjournal.com/content/12/1/10

Similar Items

Similar Items